Positive Findings in Phase 2 Study of Refractory Status Epilepticus Drug Candidate
TeroVesalainen / Pixabay

Positive Findings in Phase 2 Study of Refractory Status Epilepticus Drug Candidate

According to a recent press release from the Pennsylvania-based Marinus Pharmaceuticals, the Company is reporting positive results of its phase 2 study of "ganaxolone," an investigational GABAA modulator for patients…

Continue Reading Positive Findings in Phase 2 Study of Refractory Status Epilepticus Drug Candidate
More than 4% of People May be Immunocompromised – How Should They Approach Flu Season?
source: pixabay.com

More than 4% of People May be Immunocompromised – How Should They Approach Flu Season?

A recent publication from Healio detailed some of the challenges immunocompromised individuals might face during flu season. Influenza is a common and sometimes serious public health concern around the world, and…

Continue Reading More than 4% of People May be Immunocompromised – How Should They Approach Flu Season?
Vaping: Sleek, Tastes like Bubblegum, Still Causes Lung Disease. This Time, It’s Not Clear Why.
mohamed_hassan / Pixabay

Vaping: Sleek, Tastes like Bubblegum, Still Causes Lung Disease. This Time, It’s Not Clear Why.

Most young people are familiar with vaping: nicotine or THC repackaged in a sleek and less stigmatized device. It is less obviously recognizable as destructive as cigarettes in part because…

Continue Reading Vaping: Sleek, Tastes like Bubblegum, Still Causes Lung Disease. This Time, It’s Not Clear Why.
Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials
5239640 / Pixabay

Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials

According to a story from outsourcing-pharma.com, the company Firma Clinical Research, which provides health care services to patients in clinical trials, has been getting a lot of business lately. This…

Continue Reading Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials
Potential Treatment for Nonalcoholic Steatohepatitis Earns Fast Track Designation
sms467 / Pixabay

Potential Treatment for Nonalcoholic Steatohepatitis Earns Fast Track Designation

According to a story from sectorpublishingintelligence.co.uk, the drug company INVENTIVA's lead product candidate, known as lanifibranor, has earned Fast Track Designation from the US Food and Drug Administration (FDA) as…

Continue Reading Potential Treatment for Nonalcoholic Steatohepatitis Earns Fast Track Designation
The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis
qimono / Pixabay

The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis

According to a story from finanzen.ch, the US Food and Drug Administration (FDA) recently approved the drug rituximab (marketed as Rituxan) as a treatment in child patients aged at least…

Continue Reading The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis
Researchers Identify Link Between Immune Cells and Genetic Signatures Associated with Autoimmune Disease
allinonemovie / Pixabay

Researchers Identify Link Between Immune Cells and Genetic Signatures Associated with Autoimmune Disease

According to a publication from EurekAlert, a study recently published in the medical journal Nature Genetics suggests how certain immune cells express genetic activity similar to that of variations of the…

Continue Reading Researchers Identify Link Between Immune Cells and Genetic Signatures Associated with Autoimmune Disease